Stem Cell Research for Lung Diseases
The Respiratory BRU will take the form of an Advanced Lung Disease Unit which will provide clinical core facilities to speed up translation of current therapies into benefits for patients, create six new Consortia in key advanced lung diseases to produce a significant step-change in future research capacity, and focus translational research towards the common endpoint of these advanced lung diseases, namely chronic lung failure. The six new Consortia are: severe COPD; asthma; chronic suppurative lung disease; sleep medicine; acute respiratory failure; and interstitial lung disease.
http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_9-4-2008-16-26-54?newsid=33354